lv232

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Oct 5, 2023 (NCT06070857)

Timeline

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06828887Phase 2Mar 1, 2025Government of China, Jiao Tong University
NCT06476509Phase 1May 30, 2024Government of China, Jiao Tong University
NCT06279533Phase 1Feb 27, 2024Government of China, Jiao Tong University
NCT06070857Phase 1Oct 5, 2023Government of China, Jiao Tong University
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of ChinaGovernment4422023
Jiao Tong UniversityAcademic/Hospital4022023
2 organizations
Page 1 / 1